Koyfin Home > Directory > Health Care > LA Jolla Pharma > Net Income

LA Jolla Pharma Net Income Chart (LJPC)

LA Jolla Pharma annual/quarterly Net Income from 2010 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • LA Jolla Pharma Net Income for the quarter ending June 06, 2020 was $-16m a -87.11% increase of 14m year over year
  • LA Jolla Pharma Net Income for the last 12 months ending June 06, 2020 was $-79m a -73.93% increase of 58m year over year
  • LA Jolla Pharma Annual Net Income for 2019 was $-117m a -71.21% increase of 83m from 2018
  • LA Jolla Pharma Annual Net Income for 2018 was $-199m a 42.45% decrease of -85m from 2017
  • LA Jolla Pharma Annual Net Income for 2017 was $-115m a 31.90% decrease of -37m from 2016
Other Income Statement Metrics:
  • LA Jolla Pharma EBITDA for the quarter ending December 12, 2018 was $-42m a -17.59% increase of 7m year over year
  • LA Jolla Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a 97.55% increase of 3m year over year
View Chart On Koyfin

Quarterly LJPC Net Income Data

06/2020$-16m
03/2020$-9m
12/2019$-25m
09/2019$-29m
06/2019$-30m
03/2019$-32m
12/2018$-45m
09/2018$-51m
06/2018$-53m
03/2018$-51m

Annual LJPC Net Income Data

2019$-117m
2018$-199m
2017$-115m
2016$-78m
2015$-42m
2014$-21m
2013$-18m
2012$-8m
2011$-12m
2010$-4m